Every discussion of vascular occlusion starts in the wrong place. It starts with the emergency. It starts with a photograph of a mottled cheek and a clinician being told to recognize it. But recognition is a comparison, and a comparison needs two terms. You cannot identify an abnormal finding if you have never built a disciplined mental reference for the expected filler injection response — the erythema, the edema and the bruising that appear after a technically sound treatment and mean nothing at all.
This is the first thing I teach, and it is the part injectors skip. As I tell every course: how can you judge what is abnormal if you do not understand what is normal? The clinician who has looked carefully at two hundred ordinary post-injection faces will see the odd one across the room. The clinician who has only ever studied complication photographs will either miss it or call an emergency on a bruise.
Normal is a trained observation, not a default assumption
In emergency medicine we do not treat "looks fine" as an assessment. Looks fine is what you say before you have looked. The equivalent error at the aesthetic chairside is glancing at a treated lip, seeing color and swelling, filing it under expected, and moving to the next patient — without ever having decided, explicitly, what expected means in that anatomical region, with that product, at that depth, in that volume.
Building the baseline is a deliberate act. It requires you to know three things cold: what each expected finding is caused by, how fast each one arrives, and how each one behaves over the following hours. Once those are fixed, the deviations announce themselves.
The three expected findings and their mechanisms
Erythema: neurogenic and mechanical, not ischemic
Localized erythema is the most common finding after any injection and it is the one most often confused with early vascular compromise — usually in the wrong direction, with clinicians reassuring themselves that a dusky patch is "just redness."
Expected erythema is a combination of the axon-reflex flare and mechanical irritation from needle passage. It is diffuse rather than mapped. It sits around the entry points and the treated subunit, not along an arterial course. It is blanchable — press it and it whitens, release and color returns briskly. It is warm or neutral to the touch, never cool. And it fades, usually within minutes to a few hours.
Two of those features do the diagnostic work. Blanchability tells you the redness is in a perfused vascular bed that is dilated, not in a bed that is congested or stagnant. Warmth tells you that bed is still receiving arterial inflow. Erythema that is cool, or that is dusky rather than pink, or that has a branching reticular edge, is not the expected response.
Edema: hydrophilic and product-dependent
Expected edema comes from two sources: the inflammatory response to tissue trauma, and the hygroscopic behavior of hyaluronic acid itself. It builds over hours, typically peaks at 24 to 48 hours, and is symmetrically distributed across the treated subunit.
Regional expectations differ enormously, and this is where a generic baseline fails. Lip tissue swells more than cheek tissue, and more unpredictably. Periorbital tissue holds fluid in a way the malar fat pad does not. A lip that is substantially swollen the morning after treatment is unremarkable. A cheek that behaves the same way is not. If your mental baseline is a single generic face, you will be alarmed by normal lips and complacent about abnormal cheeks. Our existing discussion of common lip filler reactions covers the regional picture in the perioral area in more detail.
The feature that separates expected edema from the swelling of an occlusion is proportionality and trajectory. Expected swelling is proportionate to the volume placed and the trauma delivered, and it is improving by day three. Unusual swelling — swelling that is disproportionate to what you did, accompanied by pain that is disproportionate to what you did — is one of the earliest things I want an injector to notice, because it can reflect compression as much as it reflects inflammation.
Ecchymosis: extravasated blood, and the one finding that legitimately looks alarming
Bruising is blood outside the vessel. It is not blanchable, because the pigment is interstitial rather than intravascular — and that single test separates it from most of what worries you. It evolves through the predictable hemoglobin breakdown sequence over days, and it is centered on the vessel that was punctured, which may not be where you were aiming.
Ecchymosis is also the finding most often reported by patients as an emergency, because it appears after they get home and it is dramatic. I am glad when they call. A patient who telephones in the evening to say "I have had my cheeks done before and this seems really weird, and I have a huge bruise" is a patient who should be seen in the office, promptly, regardless of how routine it sounds on the phone. Most of those visits are bruises. The value of the visit is the small number that are not, and the fact that you laid eyes on the tissue rather than triaging by anecdote.
The comparison table you should be able to run from memory
| Feature | Expected response | Concerning for ischemia |
|---|---|---|
| Color | Pink, diffuse erythema | Dusky, mottled, gray, violaceous; or pallor |
| Blanches on pressure | Yes, brisk return | Sluggish, absent, or fixed mottling |
| Distribution | Around entry points and the treated subunit | Follows a vascular territory; may extend well beyond where you injected |
| Temperature | Warm or neutral | Cool relative to the matched contralateral site |
| Pain | Present, settling, proportionate | Escalating, or disproportionate to the procedure |
| Capillary refill | Comparable to surrounding and contralateral skin | Delayed relative to both |
| Trajectory over time | Improving | Static or worsening |
No single row in that table is diagnostic on its own. Pattern is what you are reading. As I put it in the course: maybe the findings appear together, maybe you get one in isolation. Recognition is an overall view of the patient, not the interrogation of a single sign.
Build the baseline before the needle, not after
Everything above depends on having a reference for this patient, captured before you treat. That work is ten seconds long and it is the highest-yield ten seconds in the appointment.
- Photograph the untreated face. Standardized lighting, standardized angles, every time. Serial photography is the backbone of complication assessment, and it starts with the pre-treatment frame.
- Note pre-existing asymmetry, telangiectasia and pigment. A patient with a preexisting vascular malformation or a chronic violaceous patch will otherwise become an emergency at their follow-up.
- Establish a capillary refill reference. Check it on the region you are about to treat and on its contralateral match while the tissue is still untouched. Refill is only meaningful as a comparison, and the comparison you want is against that patient's own skin.
- Record the variables you will need if you have to reverse. Product, volume, plane, entry points, needle or cannula. The moment you suspect an occlusion is the moment you will need to know exactly how much product went where — and you will not reconstruct it reliably from memory under stress.
That last point is the assessment question I ask before every treatment and teach injectors to ask aloud: am I using the right product, am I in the right plane, am I using the right amount? Volume discipline is part of the baseline, not a separate topic — I do not exceed 0.1 to 0.15 mL per pass, which limits both the embolic burden if a vessel is entered and the compressive burden on vessels that were not.
These figures reflect Michelle Langston's clinical practice as taught in Empire Medical Training's hands-on curriculum. Technique is learned under supervision; this article is educational and is not a substitute for training.
Extending the baseline past the appointment
The tissue does not stop changing when the patient leaves, and detection does not either. Reticular, spider-like mottling can appear within minutes — or after the patient has gone home. That makes the patient the only observer present during a substantial part of the at-risk window, and it makes their baseline knowledge a clinical variable you control.
Teach them what expected looks like in the same terms you use yourself: redness that fades, swelling that peaks and then improves, bruising that changes color and shrinks. Then teach them the deviations that mean a telephone call rather than a wait-and-see: pain that is getting worse instead of better, skin that looks blotchy or gray, a cool patch, and any visual symptom whatsoever. A patient who has been given a baseline partners with you on your safety plan. A patient who has been told "some swelling and bruising is normal" has been given nothing usable.
Why this is the first spoke in the cluster
Injectors want the algorithm. They want the dose of hyaluronidase and the protocol card, and those matter — how and when to dissolve filler is its own body of knowledge. But the protocol only fires if somebody pulls the trigger, and the trigger is a clinician noticing that this face does not look like the faces they have trained themselves to expect.
That recognition is built the same way it is built in trauma: deliberate exposure, structured observation, and the same sequence every time. It is also why anatomy sits underneath all of it. Knowing the arterial territory of the region you are treating turns "that mottling is in an odd place" into "that mottling is in the distribution of the vessel I was near," which is a different sentence with a different urgency. Training that puts you in front of supervised, structured anatomical assessment is how that reference gets built at speed.
If you are developing your injectable practice, Empire's Complete Dermal Filler Training and Complete Facial Aesthetic Training cover filler technique with hands-on supervision, which is the setting where a normal baseline is actually acquired — under someone who can tell you, in the moment, whether what you are looking at is expected.
Related guides in this cluster
Part of Vascular Occlusion: Recognition and Response.
Clinical GuideThe Golden Triangle — Why the Filler Deposit Site Isn't Where You Put the Needle InThe filler deposit site sits at the needle tip, not the entry point — about half an inch away, further with a cannula. Why that gap dec
Clinical GuideImmediate, Early and Late — The Three Windows of Vascular Occlusion OnsetVascular occlusion onset is not one moment. Organize the picture into immediate, early and late windows — detection runs days past the
Clinical GuideThe Five-Step Perfusion Exam — Reading the Signs of Vascular Occlusion in SequenceThe signs of vascular occlusion are only reliable inside a fixed sequence: scan, pain trajectory, capillary refill, temperature, vascul
Train with Empire
This guide is clinical education. The technique behind it is taught hands-on, on live patients, with faculty beside you.
Explore Complete Dermal Filler Training →Disclaimer
This article reflects the clinical opinions and experience of Michelle Langston, APRN, MSN, FNP-BC, an independent faculty member contributing to Empire Medical Training's curriculum. The views expressed are the author's own and do not necessarily represent those of Empire Medical Training.
It is professional education, not medical advice, and is no substitute for hands-on training or independent clinical judgment. Licensed clinicians remain responsible for their own patient selection, technique and outcomes, for verifying current product labelling, and for practising within their scope and applicable law. Empire Medical Training accepts no liability for reliance on this content.



